Condition (MeSH)
Prosthesis-Related Infections
ClinicalTrials.gov lists 35 trials for Prosthesis-Related Infections or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
35 of the 35 trials are tagged with Prosthesis-Related Infections itself; the rest are tagged with a narrower condition beneath it.
When did Prosthesis-Related Infections trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 6 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 3 |
| 2022 | 1 |
| 2020 | 3 |
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 2 |
| 2016 | 2 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Prosthesis-Related Infections trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 2 |
| Phase 4 | 5 |
| Not applicable | 12 |
| Observational | 15 |
How many Prosthesis-Related Infections trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 6 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
| Completed | 16 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Prosthesis-Related Infections trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Aesculap AG | 1 |
| BioMed Valley Discoveries, Inc | 1 |
Which drugs are being tested for Prosthesis-Related Infections? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Dalbavancin | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Base Monotherapy | 1 |
| Oral Antibiotics | 1 |
| Rifampin-combination therapy | 1 |
| Hyperbaric oxygen treatment | 1 |
| Medicinal gas - oxygen (Nippon Gases 200 bar) | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Prosthesis-Related Infections trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Readmission | 32 | 1 |
| Reoperation | 16 | 1 |
| Venous Thrombosis | 4 | 1 |
| Fall | 3 | 1 |
| Fibrosis | 3 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Prosthesis-Related Infections? (640)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Intraosseous vs. intravenous vancomycin administration in total shoulder arthroplasty: comparable tissue concentrations with better control. | Journal of shoulder and elbow surgery | 2026 | Yes |
| Laser Disinfection Acts as Biofilm-Disrupter in Periprosthetic Joint Infection (PJI). | Journal of orthopaedic research : official publication of the Orthopaedic Research Society | 2026 | Yes |
| REview and improvement of cardiac implanTable device Infection management qualitY initiative (RECTIFY): Rationale and design for a cardiac implantable electronic device infection quality initiative demonstration project. | American heart journal | 2026 | Yes |
| Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study. | Journal of the American College of Cardiology | 2026 | Yes |
| Superior Clinical Results With Intraosseous Vancomycin in Primary Total Knee Arthroplasty. | The Journal of arthroplasty | 2025 | Yes |
Showing 5 of 640 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.